Remdesivir for COVID‐19: evidence review of the clinical benefit and harm

Simple item page
dc.contributor.authorBlockman, M.
dc.contributor.authorCohen, K.
dc.contributor.authorDe Waal, R.
dc.contributor.authorGray, A.
dc.contributor.authorKredo, T.
dc.contributor.authorMaartens, G.
dc.contributor.authorNel, J.
dc.contributor.authorParrish, A.
dc.contributor.authorRees, H.
dc.contributor.authorReubenson, G.
dc.contributor.departmentSD and TK (Cochrane South Africa, South  African Medical Research Council, SA GRADE Network)en_US
dc.date.accessioned2020-07-20T09:02:06Z
dc.date.available2020-07-20T09:02:06Z
dc.date.epub2020-06-24
dc.date.issued2020-06-24
dc.description.sponsorshipInstitut National de la Santé Et de la Recherche  Médicale, France  Information provided by (Responsible Party):  Institut National de la Santé Et de la Recherche  Médicale, France en_US
dc.identifier.urihttps://infospace.mrc.ac.za/handle/11288/595265
dc.language.isoenen_US
dc.publisherSouth African National Department of Health en_US
dc.research.unitSouth African Cochrane Centreen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.title Remdesivir for COVID‐19: evidence review of the clinical benefit and harmen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Blockman M_2020_Remdesivir for.pdf
Size:
645.96 KB
Format:
Adobe Portable Document Format
Description:
Thumbnail Image
Name: Blockman M_2020_Remdesivir for.pdf
Size: 645.96 KB
Kind: Adobe PDF
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Name: license.txt
Size: 1.71 KB
Kind: License
Collections
Intramural: Journal Articles